About MediBeacon
MediBeacon is a Healthcare company based in St. Louis (United States) founded in 2011 by Richard Dorshow and Steve Hanley. Non-invasive optical monitoring of kidney function is developed. MediBeacon has raised $110.71 million across 12 funding rounds from investors including HHS, Huadong Medicine and St Louis City Health Dept. MediBeacon has completed 1 acquisition, including Mannheim Pharma & Diagnostics. Its chief executive, as recorded, is Steve Hanley. Its focus areas include Life Sciences, Nephrology, Medical Devices and Monitoring Devices.
Company details
MediBeacon is an optical diagnostic company that focuses on providing clinicians with critical patient information. MediBeacon creates light-activated agents, for non-invasive real-time kidney function monitoring system is in human clinical trials. Optical Renal Function Monitor (ORFM) is companys first product platform. This system is focused on real-time monitoring of kidney function. The company claims to hold multiple patents on its light-activated agents and has products for Nephrology and Gastroenterology in pipeline as on Dec15. Real-time point-of-care measurement of renal function is used to improve patient outcomes in the ICU and the operating suite and to achieve optimal dosing strategies for nephrotoxic drug interventions such as chemotherapeutics and imaging contrast agents.
- Headquarters St. Louis, United States
- Founders Richard Dorshow, Steve Hanley
- SectorsHealthcare
- Website medibeacon.com
- Social LinkedIn X
- Total Equity Funding$110.71M (USD)
in 12 rounds
- Latest Funding Round$16.09M (USD), Series D
Aug 2023
- InvestorsHHS
& 6 more
- Investments & Acquisitions
Funding Insights of MediBeacon
MediBeacon has successfully raised a total of $110.71M across 12 strategic funding rounds. The most recent funding activity was a Series D round of $16.09 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $110.71M
- Total Rounds 12
- Last Round Series D — $16.09M
- First Round $3.5M
(Aug 2013)
- Investors Count 7
Latest 10 of 12 funding rounds of MediBeacon with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2023 | $16.09M | Series D | – | – | – |
| Nov 2022 | $10M | Series C | – | Huadong Medicine | – |
| Jan 2022 | $8.13M | Series C | – | – | – |
| Sep 2019 | $34.34M | Series C | – | – | – |
| Dec 2018 | $1.25M | Debt – Conventional | – | – | – |
| May 2018 | $2.1M | Debt – Conventional | – | – | – |
| Jan 2018 | $4.58M | Debt – Conventional | – | – | – |
| Mar 2017 | $11.2M | Series B | – | HC2 Holdings | – |
| Sep 2016 | $162,321 | Grant | – | – | |
| Sep 2015 | $22.4M | Series B | – | – | – |
7 investors in total: 7 institutional.
Investors in MediBeacon
MediBeacon has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Huadong Medicine and St Louis City Health Dept.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech companies focused VC firm operating across Missouri | missouritechnology.com | Jefferson City, United States | ||
Private equity firm focused on acquisitions | 2007 | helix-investments.com | Port Louis, Mauritius | |
Venture capital and acceleration are provided to life science startups. | biogeneratorventures.com | St. Louis, United States | ||
Pharmaceutical products are manufactured and traded domestically and overseas. | 1993 | eastchinapharm.com | Hangzhou, China | |
Investments are directed toward infrastructure, life sciences, and media sectors. | 1994 | hc2.com | Herndon, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Online citizen platform | stlouis-mo.gov | United States |
Investor details for MediBeacon
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MediBeacon
23 people are tracked at MediBeacon (10 in leadership, 6 in board & advisors, 7 in team).
| Name | Role | Group |
|---|---|---|
Richard Dorshow | Co-Founder & CSO | Leadership |
Steve Hanley | Co-Founder & CEO | Leadership |
Stuart L Goldstein | Director of Clinical Development | Leadership |
Richard B. Dorshow | Chief Scientific Officer, President & Co-Founder | Leadership |
Steven J. Hanley | CEO & Co-Founder | Leadership |
Paul Trelford | Director Of Research and Development | Leadership |
Terence H. Stern | VP & Corporate Officer | Leadership |
Steven B. Miller | Chief Medical Officer | Leadership |
James M. Harr | VP, Research & Development | Leadership |
Jim Harr | Vice President of Research and Development | Leadership |
Cherine E. Plumaker | Director | Board & advisors |
David A. Present | Director | Board & advisors |
Joseph V. Bonventre | Advisor | Board & advisors |
Richard J. Solomon | Advisor | Board & advisors |
Joseph V. Nally | Advisor | Board & advisors |
Phillip I. Tarr | Advisor | Board & advisors |
Sabine Neudecker | Project Engineer | Team |
Dzmitry Stsepankou | Senior Software Engineer Research Development | Team |
Christine R. Cooke | Corporate Attorney | Team |
Jesse Ross-Jones | Research And Development Engineer | Team |
3 more people are available in the full profile.
Complete people profiles for MediBeacon
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MediBeacon
MediBeacon has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Mannheim Pharma & Diagnostics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of diagnostic solutions for gastrointestinal microbial assessment and measurement | mapdiagnostics.com | Mannheim, Germany | 0 | Jun 2016 | •••• |
Complete acquisition details for MediBeacon
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of MediBeacon
4 dated milestones of MediBeacon across 12 years, from founding to its latest funding, stage changes and deals.
- Founded MediBeacon is founded.
- Funding First funding round of $3.5M.
- Acquisition Acquires Mannheim Pharma & Diagnostics.
- Funding Latest funding round, Series D, of $16.1M.
Web traffic of MediBeacon
The website of MediBeacon (medibeacon.com) receives about 3.2K visits a month.
- Monthly visits3.2K
▲ 50.8% vs previous month
Top companies in Nephrology
3 companies that operate in the same segment as MediBeacon (Nephrology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Hemodialysis machines with touchscreen displays are provided for medical use. | 2003 | San Jose, California, United States | USD 457.87 M | USD 119.48 M | ||
Therapeutics for kidney disease treatment are developed by Akebia Therapeutics. | 2007 | Cincinnati, Ohio, United States | USD 91 M | USD 236.2 M | 181 | |
Developer of portable hemodialysis device | 2013 | Irvine, California, United States | USD 82.5 M | 40 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Medibeacon
Complete news archive for MediBeacon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MediBeacon
MediBeacon was founded in 2011 and raised its 1st funding round 2 years after it was founded.
MediBeacon is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Steve Hanley is the CEO of MediBeacon, as recorded in our data. They have also founded this company.
MediBeacon is a funded company, having raised a total of $110.71M across 12 funding rounds to date. The company's 1st funding round was a Series B of $22.4M, raised on Aug 2013.
MediBeacon is an optical diagnostic company that focuses on providing clinicians with critical patient information. MediBeacon creates light-activated agents, for non-invasive real-time kidney function monitoring system is in human clinical trials. Optical Renal Function Monitor (ORFM) is companys first product platform. This system is focused on real-time monitoring of kidney function. The company claims to hold multiple patents on its light-activated agents and has products for Nephrology and Gastroenterology in pipeline as on Dec15. Real-time point-of-care measurement of renal function is used to improve patient outcomes in the ICU and the operating suite and to achieve optimal dosing strategies for nephrotoxic drug interventions such as chemotherapeutics and imaging contrast agents.
MediBeacon has made 1 acquisition, including Mannheim Pharma & Diagnostics.
MediBeacon has 7 investors. Key investors include HHS, Huadong Medicine, St Louis City Health Dept, Helix Investments, and HC2 Holdings.